Pamela L Zeitlin is an expert in Pulmonology at National Jewish Health (United States). As of October 2026, ScienceLeadR ranks Pamela L Zeitlin in the top 1% of experts worldwide for Cystic Fibrosis and Pancreatic Diseases. Pamela L Zeitlin has authored 169 publications, the most recent in 2026, and is an investigator in 9 clinical trials. SLR score: 638 (community average: 125). How the SLR is computed.

LeadR Profile

Pamela L Zeitlin National Jewish Health United States
638 ScienceLeadR Reputation 638
Network Map

Pulmonology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1988 - 2026

Source: PubMed

National Jewish Health

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Discussing the potential health impacts of carrying a single CF-causing CFTR mutation during consult with people with CF who are planning a pregnancy.
PMID 41813504 — pregnancy, cystic fibrosis, mutation
J Cyst Fibros20260
PrecISE- A Biomarker Stratified Adaptive Trial of 5 Interventions in Severe Asthma: Final Protocol and the Baseline Cohort.
PMID 41707916 — multiple chronic conditions, eosinophils, biomarkers, diagnosis, asthma
J Allergy Clin Immunol20260
A common polymorphism in the Intelectin-1 gene influences mucus plugging in severe asthma.
PMID 38724552 — biological science disciplines, epithelial cells, genes, asthma, gene expression, interleukin-13
Nat Commun20244
Epithelial Barrier Defects in Pediatric Asthma
OpenAlex W4319083819 — cells, asthma, infections
J Allergy Clin Immunol20230
Net benefit of ivacaftor during prolonged tezacaftor/elexacaftor exposure in vitro.
PMID 35248469 — cystic fibrosis, cells, therapeutics, dimethyl sulfoxide
J Cyst Fibros20224

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

Phase 3 5
Phase 2 2
N/A 1
Phase 1/Phase 2 1

By status:

Completed 8
Terminated 1

By type:

Interventional 8
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 1
multicentric5to9 0
multicentricup10 6

Main Topics

Cohort/Consortium Investigators 3

LeadR Networks

Main global connection map